Mineralys Therapeutics (NASDAQ:MLYS) Earns Buy Rating from HC Wainwright
Mineralys Therapeutics (NASDAQ:MLYS – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a report issued on Thursday,Benzinga reports. They currently have a $30.00 target price on the stock. HC Wainwright’s price target points to a potential upside of 192.97% from the company’s current price. Mineralys Therapeutics Stock […]
Mineralys Therapeutics (NASDAQ:MLYS – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a report issued on Thursday,Benzinga reports. They currently have a $30.00 target price on the stock. HC Wainwright’s price target points to a potential upside of 192.97% from the company’s current price. Mineralys Therapeutics Stock […]